Disposition, metabolism and pharmacokinetics of antihyperlipidemic agents in laboratory animals and man

Pharmacol Ther. 1985;29(2):157-204. doi: 10.1016/0163-7258(85)90028-2.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Binding Sites
  • Biological Availability
  • Biotransformation
  • Clofibrate / metabolism
  • Drug Interactions
  • Humans
  • Hypolipidemic Agents / blood
  • Hypolipidemic Agents / metabolism*
  • Intestinal Absorption
  • Kidney Diseases / metabolism
  • Kinetics
  • Liver Diseases / metabolism
  • Mixed Function Oxygenases / metabolism
  • Niacin / metabolism
  • Protein Binding
  • Species Specificity
  • Tissue Distribution

Substances

  • Hypolipidemic Agents
  • Niacin
  • Mixed Function Oxygenases
  • Clofibrate